Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo

Identifieur interne : 002205 ( Main/Exploration ); précédent : 002204; suivant : 002206

Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo

Auteurs : Christopher M. Ward [Royaume-Uni] ; Michal Pechar ; David Oupicky [Royaume-Uni] ; Karel Ulbrich ; Leonard W. Seymour [Royaume-Uni]

Source :

RBID : ISTEX:EC6797B8675BC0BBBA5E95555AAE701AD751F17C

English descriptors

Abstract

Background: Gene delivery vectors based on poly(L‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application in vivo since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers. Methods: pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da. Results: Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells in vivo. Folate receptor targeting is shown to mediate targeted association with HeLa cells in vitro, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA. Conclusions: We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for in vivo applications. Copyright © 2002 John Wiley & Sons, Ltd.

Url:
DOI: 10.1002/jgm.296


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
<author>
<name sortKey="Ward, Christopher M" sort="Ward, Christopher M" uniqKey="Ward C" first="Christopher M." last="Ward">Christopher M. Ward</name>
</author>
<author>
<name sortKey="Pechar, Michal" sort="Pechar, Michal" uniqKey="Pechar M" first="Michal" last="Pechar">Michal Pechar</name>
</author>
<author>
<name sortKey="Oupicky, David" sort="Oupicky, David" uniqKey="Oupicky D" first="David" last="Oupicky">David Oupicky</name>
</author>
<author>
<name sortKey="Ulbrich, Karel" sort="Ulbrich, Karel" uniqKey="Ulbrich K" first="Karel" last="Ulbrich">Karel Ulbrich</name>
</author>
<author>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W." last="Seymour">Leonard W. Seymour</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:EC6797B8675BC0BBBA5E95555AAE701AD751F17C</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/jgm.296</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7KRBHKSQ-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001291</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001291</idno>
<idno type="wicri:Area/Istex/Curation">001291</idno>
<idno type="wicri:Area/Istex/Checkpoint">001032</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001032</idno>
<idno type="wicri:doubleKey">1099-498X:2002:Ward C:modification:of:pll</idno>
<idno type="wicri:Area/Main/Merge">002227</idno>
<idno type="wicri:Area/Main/Curation">002205</idno>
<idno type="wicri:Area/Main/Exploration">002205</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
<author>
<name sortKey="Ward, Christopher M" sort="Ward, Christopher M" uniqKey="Ward C" first="Christopher M." last="Ward">Christopher M. Ward</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX</wicri:regionArea>
<wicri:noRegion>Manchester M20 4BX</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Correspondence address: Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX</wicri:regionArea>
<wicri:noRegion>Manchester M20 4BX</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pechar, Michal" sort="Pechar, Michal" uniqKey="Pechar M" first="Michal" last="Pechar">Michal Pechar</name>
<affiliation>
<wicri:noCountry code="subField">Republic</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Oupicky, David" sort="Oupicky, David" uniqKey="Oupicky D" first="David" last="Oupicky">David Oupicky</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA</wicri:regionArea>
<orgName type="university">Université de Birmingham</orgName>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ulbrich, Karel" sort="Ulbrich, Karel" uniqKey="Ulbrich K" first="Karel" last="Ulbrich">Karel Ulbrich</name>
<affiliation>
<wicri:noCountry code="subField">Republic</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W." last="Seymour">Leonard W. Seymour</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA</wicri:regionArea>
<orgName type="university">Université de Birmingham</orgName>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">The Journal of Gene Medicine</title>
<title level="j" type="alt">JOURNAL OF GENE MEDICINE, THE</title>
<idno type="ISSN">1099-498X</idno>
<idno type="eISSN">1521-2254</idno>
<imprint>
<biblScope unit="vol">4</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="536">536</biblScope>
<biblScope unit="page" to="547">547</biblScope>
<biblScope unit="page-count">12</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2002-09">2002-09</date>
</imprint>
<idno type="ISSN">1099-498X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1099-498X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acid binding</term>
<term>Albumin concentrations</term>
<term>Aliquot portions</term>
<term>Amersham pharmacia</term>
<term>Analyser</term>
<term>Aqueous solubility</term>
<term>Bind blood cells</term>
<term>Bioconjug chem</term>
<term>Biol chem</term>
<term>Blood cell</term>
<term>Blood cell binding</term>
<term>Blood cells</term>
<term>Body distribution</term>
<term>Cancer cells</term>
<term>Cancer research</term>
<term>Cationic polymer</term>
<term>Cell lines</term>
<term>Cellular uptake</term>
<term>Chem</term>
<term>Christie hospital</term>
<term>Circulation properties</term>
<term>Circulation times</term>
<term>Coating complexes</term>
<term>Competitive inhibition</term>
<term>Copper grids</term>
<term>Copyright</term>
<term>Covalent</term>
<term>Covalent linkage</term>
<term>Czech republic</term>
<term>Diethyl ether</term>
<term>Dos</term>
<term>Dose polymer</term>
<term>Ester</term>
<term>Expression vector</term>
<term>Folate</term>
<term>Folate conjugates</term>
<term>Folate receptor</term>
<term>Folate receptors</term>
<term>Folic</term>
<term>Folic acid</term>
<term>Free polymer</term>
<term>Fresh media</term>
<term>Gene delivery</term>
<term>Hela</term>
<term>Hela cells</term>
<term>Hepes buffer</term>
<term>High dose</term>
<term>High dose polymer</term>
<term>High dose polymer complexes</term>
<term>High doses</term>
<term>Higher doses</term>
<term>Human serum</term>
<term>Hydrolysed polymer</term>
<term>Hydrophilic polymers</term>
<term>Independent experiments</term>
<term>Integration time</term>
<term>Intravenous injection</term>
<term>John wiley sons</term>
<term>Lateral stabilisation</term>
<term>Liquid scintillation analyser</term>
<term>Luminescence spectrometer</term>
<term>Lysosomal cathepsins</term>
<term>Meantstandard deviation</term>
<term>Molecular weight sartorius</term>
<term>Multivalent</term>
<term>Nitrocellulose membrane</term>
<term>Ovarian cancer patients</term>
<term>Paterson institute</term>
<term>Plasma circulation</term>
<term>Plasma fraction</term>
<term>Polyelectrolyte</term>
<term>Polyelectrolyte complexes</term>
<term>Polymer</term>
<term>Polymer coating</term>
<term>Polymer complexes</term>
<term>Preformed complexes</term>
<term>Protein binding</term>
<term>Radioactivity assay</term>
<term>Rapid clearance</term>
<term>Reactive</term>
<term>Reactive esters</term>
<term>Receptor</term>
<term>Results show</term>
<term>Room temperature</term>
<term>Scintillation</term>
<term>Scintillation analyser</term>
<term>Serum protein binding</term>
<term>Serum proteins</term>
<term>Seymour</term>
<term>Simple complexes</term>
<term>Slit widths</term>
<term>Solid product</term>
<term>Spacer</term>
<term>Spacer length</term>
<term>Stock solution</term>
<term>Such vectors</term>
<term>Sucrose solution</term>
<term>Surface charge</term>
<term>Systemic circulation</term>
<term>Target cells</term>
<term>Total luciferase protein expression</term>
<term>Total protein concentration</term>
<term>Transfection</term>
<term>Transgene</term>
<term>Transgene expression</term>
<term>Transmission electron microscope</term>
<term>Transmission electron microscopy</term>
<term>Tumour cells</term>
<term>Turbidity</term>
<term>Turbidometric analysis</term>
<term>Ultracentrifuge tube</term>
<term>Untargeted complexes</term>
<term>Uptake</term>
<term>Uranyl acetate stain</term>
<term>Various concentrations</term>
<term>Vector surface</term>
<term>Vivo</term>
<term>Vivo applications</term>
<term>Vivo studies</term>
<term>Wilmslow road</term>
<term>Zeta</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Gene delivery vectors based on poly(L‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application in vivo since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers. Methods: pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da. Results: Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells in vivo. Folate receptor targeting is shown to mediate targeted association with HeLa cells in vitro, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA. Conclusions: We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for in vivo applications. Copyright © 2002 John Wiley & Sons, Ltd.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Midlands de l'Ouest</li>
</region>
<settlement>
<li>Birmingham</li>
</settlement>
<orgName>
<li>Université de Birmingham</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Pechar, Michal" sort="Pechar, Michal" uniqKey="Pechar M" first="Michal" last="Pechar">Michal Pechar</name>
<name sortKey="Ulbrich, Karel" sort="Ulbrich, Karel" uniqKey="Ulbrich K" first="Karel" last="Ulbrich">Karel Ulbrich</name>
</noCountry>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Ward, Christopher M" sort="Ward, Christopher M" uniqKey="Ward C" first="Christopher M." last="Ward">Christopher M. Ward</name>
</noRegion>
<name sortKey="Oupicky, David" sort="Oupicky, David" uniqKey="Oupicky D" first="David" last="Oupicky">David Oupicky</name>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W." last="Seymour">Leonard W. Seymour</name>
<name sortKey="Ward, Christopher M" sort="Ward, Christopher M" uniqKey="Ward C" first="Christopher M." last="Ward">Christopher M. Ward</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002205 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002205 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:EC6797B8675BC0BBBA5E95555AAE701AD751F17C
   |texte=   Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021